Omthera Pharmaceuticals, Inc.

Omthera Pharmaceuticals, Inc.

Omthera Pharmaceuticals, Inc.

Overview
Date Founded

2008

Headquarters

707 State Road, Princeton, NJ, 08540, USA

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Pharmaceuticals
Hospitals & Patient Services
Medical Support Services
Biotechnology

Company Description

Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ.

Executives & Employees

Co-Founder, President & Chief Executive Officer

Chief Medical Officer & Co-Founder

Vice President, Finance & Chief Financial Officer

Executive Vice President & Chief Operating Officer

Director, Regulatory Affairs

Vice President, Quality

Vice President, CMC & Manufacturing

Senior Manager

Board of Directors

In-House Counsel at AstraZeneca Plc

Paths to Omthera Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Omthera Pharmaceuticals, Inc.
Recent Transactions
Details Hidden

AstraZeneca Plc purchases Omthera Pharmaceuticals, Inc.

Details Hidden

Omthera Pharmaceuticals, Inc. issued Common Stock

Details Hidden

Omthera Pharmaceuticals, Inc. raised money in a private placement transaction

Transaction Clients
Investment Advisor

Advised on Bristol-Myers Squibb Company purchases Medarex, Inc.

Transaction Advisors
Underwriter

Advised onOmthera Pharmaceuticals, Inc. issued Common Stock

Legal Advisor

Advised onAstraZeneca Plc purchases Omthera Pharmaceuticals, Inc.

Legal Advisor

Advised onOmthera Pharmaceuticals, Inc. issued Common Stock

Associate

Advised onAstraZeneca Plc purchases Omthera Pharmaceuticals, Inc.

Associate

Advised onAstraZeneca Plc purchases Omthera Pharmaceuticals, Inc.

Legal Advisor

Advised onAstraZeneca Plc purchases Omthera Pharmaceuticals, Inc.

Advisors & Consultants
Legal Advisor

National Co-Chair, Life Sciences Practice at Goodwin Procter LLP

Key Stats and Financials As of
Market Capitalization
$325M
Total Enterprise Value
Earnings Per Share
Investors
Details Hidden

New Enterprise Associates (NEA) focuses on investments in the technology and healthcare sectors. The firm's investment strategy spans all stages of a company's growth, from seeding innovations in emerging markets to funding early-stage companies in high-growth markets to fueling the growth of market leaders. NEA actively invests in emerging markets, with emphasis on India and China.NEA's investments in the healthcare sector focus on companies that address unmet or underserved clinical needs and that combine improved clinical outcomes with lower costs to the market. The firm targets three areas including biopharmaceuticals, medical devices and healthcare services. The firm has a history of partnering with companies that have pioneered transformative innovations in healthcare, such as balloon angioplasty and laparoscopic surgeryWithin the technology sector, NEA focuses on investments in the electronics, consumer technology, enterprise mobility, virtualization, tech-enabled services, SaaS and cloud computing industries.

Details Hidden

Sofinnova Partners is an active manager which invests exclusively in life sciences and information technology firms in France, Europe, and to a limited extent, the US. They also have expertise in the clean technology sector. The firm aims to build companies from seed rounds to a trade sale or an IPO, investing in start-ups and early-stage companies with ambitious projects. They prefer to invest in companies capable of attracting European investors, contributing a minimum of 0.5 million euros per investment, and up to 20 million euros over several rounds of financing.Sofinnova Partners acts as lead or co-lead investor, taking a seat on the board of directors and seeking to bring added value to the investee company management team. The firm builds alliances, teaming up with other venture capitalists so that the investee company can cover their future capital needs and expand.In Information Technology, Sofinnova Partners aims to identify new trends and technological breakthroughs in areas such as materials, photonics and micro-electronics, embedded software and user interfaces for wireless and consumer electronics and IT infrastructure software solutions. The firm maintains a best-practice approach, teaming up with experts who combine scientific knowledge and business experience to help in their selection process.In Life Sciences, Sofinnova Partners focuses on ambitious seed and start-up projects developing new therapeutics in biopharmaceuticals and medical devices and give special attention to spin-offs or teams which leave companies in these two sectors, seeking to invest in companies which develop new products for unmet clinical needs, address big markets and which combine entrepreneurial and pharmaceutical experience.

Details Hidden

Founder at Corvidia Therapeutics, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Omthera Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Omthera Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Omthera Pharmaceuticals, Inc..